The BBRA Autism study is evaluating if an investigational drug is safe and able to reduce irritability in children and adolescents with Autism Spectrum Disorder.
CONTACT US ABOUT AUTISM TRIAL
Autism Spectrum Disorder (Youth 5-17)
Description
Eligibility Criteria
5-17 Years Old; Have been diagnosed with ASD by a medical doctor; Experiencing irritability due to ASD
Duration
20 weeks
Intervention
Participants will receive age and weight dependent flexible doses of Cariprazine once daily for 8 weeks.
Compensation
$75/Visit
Categories
- Youth Clinical Trial